Skip to content

Étiquette : Biotech Finances

🔎Important perspectives on access to cardiovascular innovation in France

By bertrand

🔎Important perspectives on access to cardiovascular innovation in France March 3, 2026 A recent Le Monde op-ed signed by leading experts in interventional cardiology highlights delays in accessing cutting-edge medical devices in France — delays that may represent a real loss of opportunity for patients. At Cardiawave, we believe that patients should benefit rapidly and safely … Continued

🚀Cardiawave featured in Biotech Finances

By bertrand

🚀Cardiawave featured in BiotechFinances February 26, 2026 🚀 Cardiawave continues to push innovation while keeping clinical development efficient and impactful! We are proud to be featured in Biotech Finances following a major milestone: the CE marking for our non‑invasive ultrasound-based treatment for severe aortic stenosis. Our CEO, Carine Schorochoff, highlights our approach:👉 a highly skilled and agile … Continued